Title: Meerovitch K, et al. Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye. Clin Ophthalmol. 2013;7:1275-85.
263251-78-1
21926-01-2 | 2-Amino-1,5-pentanediol | AA00BKYP | MFCD19206206
28491-02-3 | 3-(4-Chlorophenoxy)pyrrolidine | AA00BNLL | MFCD08687447
287476-24-8 | D-ALANINE-15N | AA00BOQ3
2266-41-3 | 4-Fluorobenzenesulfonohydrazide | AA00BS5U | MFCD00051748
2442-31-1 | 8-hydroxycoumarin | AA00BUF5 | MFCD18450722
3018-68-6 | 2-METHYL-1-PHENYL-1H-BENZIMIDAZOL-5-AMINE HYDROCHLORIDE | AA00BWAQ | MFCD08447136
40017-58-1 | 2-Amino-3-(2-chlorobenzoyl)thiophene | AA00BXAN | MFCD07787592
37928-17-9 | 5-Methyl-3,4-diphenylisoxazole | AA00BXHJ | MFCD18449672
37964-17-3 | Ethyl 1H-pyrrole-3-carboxylate | AA00BXNU | MFCD10000696
331763-60-1 | Fmoc-(R)-3-amino-4-(4-chloro-phenyl)-butyric acid | AA00BXTE | MFCD01860904